Phibro Animal Health Corporation Revenue
Phibro Animal Health Corporation (PAHC) reported Revenue of $1.52 billion for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-26.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-26
- Phibro Animal Health Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $396.75M, a 4.77% increase year-over-year.
- Phibro Animal Health Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $383.54M, a 10.27% increase year-over-year.
- Phibro Animal Health Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $373.91M, a 20.90% increase year-over-year.
- Phibro Animal Health Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $363.89M, a 39.73% increase year-over-year.
- Phibro Animal Health Corporation revenue from contract with customer, excluding assessed tax for fiscal 2026 was $1.52B, a 17.12% increase from fiscal 2025.
- Phibro Animal Health Corporation revenue from contract with customer, excluding assessed tax for fiscal 2025 was $1.30B, a 27.37% increase from fiscal 2024.
- Phibro Animal Health Corporation revenue from contract with customer, excluding assessed tax for fiscal 2024 was $1.02B, a 4.07% increase from fiscal 2023.
- Phibro Animal Health Corporation revenue from contract with customer, excluding assessed tax for fiscal 2023 was $977.89M, a 3.78% increase from fiscal 2022.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $396.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-26 | $780.29M derived: sum of 2 quarters · filed 2026-08-26 | $1.15B derived: sum of 3 quarters · filed 2026-08-26 | $1.52B 10-K · filed 2026-08-26 |
| 2026-03-31 | $383.54M 10-Q · filed 2026-05-06 | $757.45M derived: sum of 2 quarters · filed 2026-05-06 | $1.12B 10-Q · filed 2026-05-06 | $1.50B derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-12-31 | $373.91M 10-Q · filed 2026-02-04 | $737.80M 10-Q · filed 2026-02-04 | $1.12B derived: sum of 3 quarters · filed 2026-08-26 | $1.46B derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-09-30 | $363.89M 10-Q · filed 2025-11-05 | $742.59M derived: sum of 2 quarters · filed 2026-08-26 | $1.09B derived: sum of 3 quarters · filed 2026-08-26 | $1.40B derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-06-30 | $378.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-26 | $726.52M derived: sum of 2 quarters · filed 2026-08-26 | $1.04B derived: sum of 3 quarters · filed 2026-08-26 | $1.30B 10-K · filed 2026-08-26 |
| 2025-03-31 | $347.82M 10-Q · filed 2026-05-06 | $657.09M derived: sum of 2 quarters · filed 2026-05-06 | $917.52M 10-Q · filed 2026-05-06 | $1.19B derived: sum of 4 quarters · filed 2026-08-26 |
| 2024-12-31 | $309.26M 10-Q · filed 2026-02-04 | $569.69M 10-Q · filed 2026-02-04 | $842.86M derived: sum of 3 quarters · filed 2026-08-26 | $1.11B derived: sum of 4 quarters · filed 2026-08-26 |
| 2024-09-30 | $260.43M 10-Q · filed 2025-11-05 | $533.60M derived: sum of 2 quarters · filed 2026-08-26 | $796.82M derived: sum of 3 quarters · filed 2026-08-26 | $1.05B derived: sum of 4 quarters · filed 2026-08-26 |
| 2024-06-30 | $273.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-26 | $536.39M derived: sum of 2 quarters · filed 2026-08-26 | $786.33M derived: sum of 3 quarters · filed 2026-08-26 | $1.02B 10-K · filed 2026-08-26 |
| 2024-03-31 | $263.22M 10-Q · filed 2025-05-07 | $513.17M derived: sum of 2 quarters · filed 2025-05-07 | $744.51M 10-Q · filed 2025-05-07 | $999.56M derived: sum of 4 quarters · filed 2025-08-27 |
| 2023-12-31 | $249.94M 10-Q · filed 2025-02-05 | $481.29M 10-Q · filed 2025-02-05 | $736.34M derived: sum of 3 quarters · filed 2025-08-27 | $982.01M derived: sum of 4 quarters · filed 2025-08-27 |
| 2023-09-30 | $231.35M 10-Q · filed 2024-11-06 | $486.40M derived: sum of 2 quarters · filed 2025-08-27 | $732.07M derived: sum of 3 quarters · filed 2025-08-27 | $976.72M derived: sum of 4 quarters · filed 2025-08-27 |
| 2023-06-30 | $255.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-27 | $500.72M derived: sum of 2 quarters · filed 2025-08-27 | $745.37M derived: sum of 3 quarters · filed 2025-08-27 | $977.89M 10-K · filed 2025-08-27 |
| 2023-03-31 | $245.67M 10-Q · filed 2024-05-08 | $490.32M derived: sum of 2 quarters · filed 2024-05-08 | $722.84M 10-Q · filed 2024-05-08 | $978.11M derived: sum of 4 quarters · filed 2024-08-28 |
| 2022-12-31 | $244.65M 10-Q · filed 2024-02-07 | $477.17M 10-Q · filed 2024-02-07 | $732.43M derived: sum of 3 quarters · filed 2024-08-28 | $972.05M derived: sum of 4 quarters · filed 2024-08-28 |
| 2022-09-30 | $232.52M 10-Q · filed 2023-11-08 | $487.79M derived: sum of 2 quarters · filed 2024-08-28 | $727.40M derived: sum of 3 quarters · filed 2024-08-28 | $960.12M derived: sum of 4 quarters · filed 2024-08-28 |
| 2022-06-30 | $255.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $494.88M derived: sum of 2 quarters · filed 2024-08-28 | $727.60M derived: sum of 3 quarters · filed 2024-08-28 | $942.26M 10-K · filed 2024-08-28 |
| 2022-03-31 | $239.62M 10-Q · filed 2023-05-03 | $472.33M derived: sum of 2 quarters · filed 2023-05-03 | $687.00M 10-Q · filed 2023-05-03 | |
| 2021-12-31 | $232.71M 10-Q · filed 2023-02-08 | $447.38M 10-Q · filed 2023-02-08 | ||
| 2021-09-30 | $214.66M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | $833.35M 10-K · filed 2023-08-30 | |||
| 2020-06-30 | $800.35M 10-K · filed 2022-08-24 |